INVOcell - Medical Device for Infertility at Fraction of the Cost of IVF
Are you aware of INVOcell a novel medical device by www.invobioscience.com ? The breakthrough medical device that has gotten CE MARK approval that enables the company to sell the device in practically every country worldwide except for the USA, which addresses a 150,000,000 infertile market according to www.eshre.com . The company is penetrating world markets on 5 Continents and plans on FDA submission this year. The procedure is administered in 2 short visits, in an office setting, with either mild or no stimulation. The INVOcell is CO2 permeable, maintains 5% co2, 6% oxygen and 37c in the vaginal cavity for a period of 3 days (the incubation period). Other advantages include cost, availability, efficiency, also the patient never leaves her embryos in an expensive IVF Center lab. The company is now a publicly traded company …recent press releases can be viewed on any financial website ..stock ticker IVOB.
Are you a doctor or a fertility expert? Are you being treated right now? We want to know about it. Register on Fertility Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.
